Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
CA Stocks

AIML.CN AI/ML Innovations Inc. CNQ at C$0.04 on 28 Feb 2026: Model signals mixed

February 28, 2026
5 min read
Share with:

AIML.CN stock opened market hours on 28 Feb 2026 at C$0.04, down 11.11% from the previous close as volume surged to 1,183,540 shares on the CNQ exchange in Canada. The move follows mixed momentum indicators and a new spotlight from a ThreeD Capital interview series that features AI/ML Innovation Inc. The stock’s micro‑cap market cap is C$6,730,560 and the company sits in the Healthcare sector with a patent‑pending personal health monitoring product set, creating a high‑volatility profile for AI stock investors.

Market snapshot and price action for AIML.CN stock

AIML.CN stock traded intraday at C$0.04 with a day high and low both at C$0.04, reflecting tight intraday pricing but significant 1‑day decline of -11.11% on 1,183,540 shares versus average volume 415,292. The 50‑day average is C$0.04 and the 200‑day average is C$0.05, while the 52‑week range is C$0.03–C$0.12, showing a recent recovery from the yearly low but persistent downside from the high.

Sponsored

Business overview: AI/ML Innovations Inc. (AIML.CN) on CNQ in Canada

AI/ML Innovations Inc. (AIML.CN) operates in digital healthcare and wearable monitoring, headquartered in Victoria, Canada, and listed on CNQ. The company focuses on a patent‑pending personal health monitoring system for caregivers and clinicians and reports negative earnings with EPS -0.03 and PE -1.33, underlining current operating losses common in early‑stage AI healthcare plays.

AIML.CN stock: Financials, valuation and Meyka grade

Key metrics show market cap C$6,730,560, shares outstanding 168,264,000, price/book 5.23, current ratio 2.09, and cash per share C$0.01, pointing to tight fundamentals and high valuation multiples versus revenue. Meyka AI rates AIML.CN with a score out of 100: Score 62.30 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. These metrics combined explain a cautious HOLD stance rather than an outright sell despite low absolute price.

AIML.CN stock technicals and trading signals

Technicals show short‑term strength and volatility: RSI 70.95 (overbought), CCI 129.96 (overbought), and OBV 1,250,137, indicating recent buying interest but low ADX 13.73 signaling no strong directional trend. Price averages (50/200) at C$0.0367 and C$0.0515 give a mixed momentum picture that can produce rapid swings for this micro‑cap AI stock.

News, catalysts and sector context for AIML.CN stock

Recent coverage includes a feature in ThreeD Capital’s YouTube interview series highlighting AIML.CN as a portfolio company, increasing investor attention and liquidity source. Peer comparison pages show market positioning versus other small healthcare AI names on Investing.com, useful for relative valuation checks source.

Risks and opportunities in the AI healthcare play

Upside comes from product adoption, licensing or partnership wins in digital health, while downside risks include recurring negative margins, negligible revenue per share C$0.00, and limited liquidity despite high intraday volume. AIML.CN stock remains speculative and highly sensitive to news and microcap flows, so position sizing and exit rules are essential for investors.

Final Thoughts

AIML.CN stock is trading at C$0.04 on 28 Feb 2026 with high intraday volume and mixed technicals, creating both speculative opportunities and meaningful downside risk. Meyka AI’s forecast model projects a 12‑month price of C$0.00843, implying a -78.92% move from today’s price; forecasts are model‑based projections and not guarantees. Our scenario price targets for practical planning are: Bear C$0.02 (‑50%), Base C$0.05 (+25%), Bull C$0.12 (+200%). The proprietary Meyka grade (Score 62.30, Grade B, Suggestion HOLD) reflects the stock’s small market cap, weak earnings, and sector comparisons, and favors monitoring catalysts rather than initiating large positions. Active traders can use tight stops and volume cues; long‑term investors should wait for clearer revenue growth and margin improvement before adding significant exposure. For more data, check AIML.CN on Meyka AI’s stock page AIML.CN on Meyka.

FAQs

What is the current price and volume for AIML.CN stock?

AIML.CN stock traded at C$0.04 on 28 Feb 2026 with volume 1,183,540 shares versus an average volume of 415,292 on the CNQ exchange in Canada.

What grade does Meyka AI assign to AIML.CN?

Meyka AI rates AIML.CN with a score out of 100: 62.30 | Grade B | Suggestion: HOLD. The grade considers sector and benchmark comparisons, growth, metrics, forecasts, and analyst signals.

What is Meyka AI’s forecast for AIML.CN stock?

Meyka AI’s forecast model projects a 12‑month price of C$0.00843, implying a -78.92% change from the current C$0.04; forecasts are model‑based projections and not guarantees.

What are the main risks for investors in AIML.CN stock?

Main risks include persistent negative earnings (EPS -0.03), high valuation ratios like PB 5.23, limited revenue per share, micro‑cap liquidity swings, and sector execution risk in AI healthcare.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
12% average open rate and growing
Trusted by 4,200+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)